Renovia CEO Marc Beer Successfully Raises $42.3 Million in Funds for Womens Healthcare

Posted on October 10, 2018

Co-founder, Chairman and CEO Marc Beer of Renovia celebrates the successful completion of $42.3 million in funding that shall pave a way for the research and diagnostics in women’s healthcare. Marc Beer who is renowned in his field of commercialization and development catering to pharmaceuticals, therapeutics, devices and diagnostics for over twenty-five years is thrilled to announce the successful completion of the Series B financing. The funding will mainly help Renovia continue with its research and development for Women’s health, focusing on pelvic floor disorders and the breakthrough research and development in the said area. Renovia was established in 2016. Learn more: https://renoviainc.com/

 

Pelvic floor disorder is known as the prolapse or the collapse of the urethra, bladder, uterus, small intestine, rectum and even the vagina due to the weakened state of ligaments caused by an injury or injuries in the connective tissues. To date, Renovia stands as one of the leaders, since 2016, in its determination to focus clinical developmental research for women with pelvic floor disorder.

 

Marc Beer recently commented on the approval and completion of the 43.2 million funds that he is thrilled to feel the support of the world’s leading healthcare investors who envision the same goals as he does. A vision, he says, to help treat and better diagnose the millions of women who share in his pursuit and dreams of living a better-quality life regardless of being affected by pelvic floor disorder.

 

Renovia is the creator of “Leva,” a digitalized pelvic healthcare system. The “Leva” kit helps women affected with pelvic floor disorder to digitally strengthen and train their pelvic floor muscles within the comfort of their own home. The Leva kit is FDA approved and created for the rehabilitation of the weakened pelvic muscles. It includes an EmbaGYN Pelvic Floor Exercise and the leva Pelvic Digital Health System. The product is both used to help and distinguish the pelvic floor disorders to better diagnose and strengthen the muscles.

 

Renovia’s success in acquiring the 42.3 Million in financial funding shall help in its clinical development to update and create new and improved digital health kits for women with the disorder. The goal of the company is to enhance current version of the kit and continue with the research in the field of women’s health at the same time create affordable products for women and healthcare providers. The products created are digitally enhanced to be easily used by women on their mobile phones. Renovia’s pipeline is set to include further research and development within the next few years since approval and completion of the funding.

 

Categories: Biotechnology, Entrepreneurs, Finance, People


Comments are closed